RecruitingNCT07251491
Psilocybin safety and dose testing for depression in Veterans with spinal cord injury
About this title
Read the official source — NCT07251491Medication studyAges 22+United States
Understand this study
Who could participate?
Listed age limits: from 22 years.
- Listed locations
- The BronxSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 6, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 22 Years
- Official registry ID
- NCT07251491
- Official title
Show the full official title
Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
The Bronx
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is James J. Peters Veterans Affairs Medical Center.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin (Usona Institute).
Who can participate?
Listed age limits: from 22 years.
Is this study still recruiting?
The registry lists this study as recruiting.
